Please select the option that best describes you:

What is the benefit of cytoreduction with Hydroxyurea for patients with newly diagnosed chronic phase CML with a WBC count >100 prior to the initiation of a TKI?   

Answer from: Medical Oncologist at Academic Institution
Medical Oncologist at Kaiser Permanente-Santa Teresa-San Jose
Hydroxyurea effects are short lived and, when used...
Medical Oncologist at Massachusetts General Hospital
Agree! The key term is used properly. The cytopeni...
at Emory University
What about in a patient with extreme leukocytosis ...
Sign in or Register to read more